Mesco Pharmaceuticals Ltd.
NSE: MESCOPHARM | BSE: 500274
₹4.54
₹0.21
(4.85%)
As on 10-Jan-2022IST
Market cap
₹9 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
--
P/B Ratio
-0.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
0 %
-
ROCE
-2.1 %
-
Industry P/E
39.9
-
EV/EBITDA
-4081.2
-
Debt to Equity
-1
-
Book Value
₹--
-
EPS
₹-0
-
Face value
10
-
Shares outstanding
20,320,600
10 Years Aggregate
CFO
₹-2.85 Cr
EBITDA
₹-51.64 Cr
Net Profit
₹-51.22 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Mesco Pharmaceuticals
| -- | -- | -7.2 | -41.0 | -27.3 | -- | -- |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
BSE Healthcare#
| 18.8 | 2.8 | 8.7 | 17.1 | 23.1 | 14.8 | 12.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Mesco Pharmaceuticals
|
4.5 | 9.2 | 0.0 | 0.0 | -- | -- | -- | -0.9 |
| 3,281.6 | 26,870.9 | 1,461.8 | 387.4 | 34.5 | 25.2 | 69.6 | 15.5 | |
| 813.5 | 16,000.2 | 7,784.0 | 688.5 | 10.6 | 14 | 23.1 | 2.7 | |
| 449.9 | 17,241.8 | 2,141.5 | 58.5 | 5.8 | 3.3 | 162.3 | 4.5 | |
| 836.7 | 20,739.4 | 5,632.3 | 662.4 | 17.2 | 14.3 | 31.3 | 4.2 | |
| 1,532.2 | 17,579.4 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.0 | |
| 218.7 | 29,103.3 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.6 | |
| 1,804.4 | 29,891.8 | 1,935.8 | 288.2 | 20.6 | 29.8 | 103.7 | 22.3 | |
| 403.4 | 16,284.0 | 3,600.2 | 221.0 | 9.7 | 5.6 | 73.7 | 3.4 | |
| 1,977.1 | 32,103.6 | 3,564.0 | 414.0 | 15.3 | 8.4 | 78.5 | 6.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Mesco Pharmaceuticals
Manufacture of allopathic pharmaceutical preparations
-
Incorporated
1986
-
Chairman
--
-
Managing Director
--
-
Headquarters
Nainital, Uttarakhand
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Mesco Pharmaceuticals
What is the current share price of Mesco Pharmaceuticals Ltd Today?
The share price of Mesco Pharmaceuticals Ltd is ₹4.54 (BSE) as of 10-Jan-2022 IST. Mesco Pharmaceuticals Ltd has given a return of -27.33% in the last 3 years.
What is the current PB & PE ratio of Mesco Pharmaceuticals Ltd?
Since, TTM earnings of Mesco Pharmaceuticals Ltd is negative, P/E ratio is not available.
The P/B ratio of Mesco Pharmaceuticals Ltd is -0.88 times as on 10-Jan-2022, a 121 discount to its peers’ median range of 4.23 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2021 |
0.00 |
0.00 |
2020 |
0.00 |
0.00 |
2019 |
0.00 |
0.00 |
2018 |
0.00 |
0.00 |
2017 |
0.00 |
0.00 |
What is the 52 Week High and Low of Mesco Pharmaceuticals Ltd?
The 52-week high and low of Mesco Pharmaceuticals Ltd are Rs -- and Rs -- as of 31-Aug-2026.
What is the market cap of Mesco Pharmaceuticals Ltd?
Mesco Pharmaceuticals Ltd has a market capitalisation of ₹ 9 Cr as on 10-Jan-2022. As per SEBI classification, it is a company.
Should I invest in Mesco Pharmaceuticals Ltd?
Before investing in Mesco Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.